Status:
COMPLETED
Brief CBT for Anxiety and Advanced Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
RATIONALE: Providing cognitive-behavioral therapy (CBT) may reduce anxiety and improve quality of life of patients with advanced cancer. PURPOSE: To examine the development and pilot testing of a bri...
Detailed Description
OBJECTIVES: * To develop and examine the feasibility and patient acceptability of administering a manualized cognitive-behavioral intervention that improves quality of life by treating anxiety in pat...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Diagnosis of incurable solid tumor cancers
- At least four weeks post-diagnosis
- Current symptoms of anxiety and anxiety as principal psychiatric problem
- Patients with co-morbid depression are eligible as long as anxiety symptoms are primary
- Concurrent pharmacotherapy for anxiety allowed
- EXCLUSION CRITERIA:
- Delirium or dementia
- Active and untreated major psychiatric condition such as schizophrenia or bipolar disorder, other psychotic disorders, or substance dependence
- Other inability to complete informed consent process or study procedures
Exclusion
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00706290
Start Date
April 1 2007
End Date
August 1 2010
Last Update
June 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114